Ep Wealth Advisors, LLC Lixte Biotechnology Holdings, Inc. Transaction History

Ep Wealth Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Jun 05, 2023	BUY	$0.51 - $1.89 $1,127 - $4,178	2,211 New	2,211 $1,000
Q4 2022 Jun 12, 2023	BUY	$0.48 - $6.0 $10,950 - $136,884	22,814 Added 1031.84%	25,025 $12,000
Q2 2022 Aug 11, 2022	SELL	$0.12 - $0.35 $3,003 - $8,758	-25,025 Closed	0 $0
Q1 2022 May 20, 2022	BUY	$0.16 - $0.35 $4,004 - $8,758	25,025 New	25,025 $31,000

Ticker LIXT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,646,600
Market Cap $33M
Description
Lixte Biotechnology Holdings, Inc. operates as a drug discovery company that uses biomarker technology to identify enzyme targets related with serious common diseases and designs novel compounds to attack those targets. The company primarily focuses on inhibitors of protein phosphatases that are used alone and in combination with cytotoxic agent...

Get notified when there are updates to the investment portfolio of Ep Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Ep Wealth Advisors, LLC with notifications on news.